Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,644	11,112	12,824	20,078	28,796	20,702
Market Cap Growth	33.01%	-13.35%	-36.13%	-30.28%	39.10%	126.07%
Enterprise Value	9,479	9,530	10,935	17,327	25,931	18,996
Last Close Price	33.99	34.67	39.39	61.04	86.98	62.29
PE Ratio	39.09	30.31	31.58	33.42	34.08	54.34
Forward PE	24.57	17.53	18.53	25.87	39.80	50.27
PS Ratio	4.72	4.87	5.62	7.01	13.55	14.77
PB Ratio	2.34	2.41	2.89	4.84	7.91	7.44
P/TBV Ratio	3.36	3.46	3.98	6.17	9.42	9.25
P/FCF Ratio	76.19	67.36	177.91	59.37	74.39	34.07
P/OCF Ratio	39.71	38.10	51.45	31.75	48.66	29.72
EV/Sales Ratio	4.20	4.17	4.79	6.05	12.20	13.55
EV/EBITDA Ratio	30.91	23.17	26.63	27.65	52.80	58.29
EV/EBIT Ratio	47.26	31.08	34.94	30.69	58.67	62.69
EV/FCF Ratio	67.85	57.77	151.70	51.24	66.99	31.26
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.00	0.01
Debt / EBITDA Ratio	0.10	0.06	0.04	0.04	0.01	0.08
Debt / FCF Ratio	0.22	0.14	0.25	0.08	0.02	0.04
Asset Turnover	0.40	0.40	0.41	0.55	0.48	0.40
Inventory Turnover	4.38	4.09	4.53	4.84	3.58	3.93
Quick Ratio	2.12	2.09	2.27	2.68	2.69	2.36
Current Ratio	2.91	2.59	2.69	2.95	3.02	2.62
Return on Equity (ROE)	6.38%	8.41%	9.60%	15.72%	26.44%	14.65%
Return on Assets (ROA)	2.24%	3.39%	3.55%	6.79%	6.25%	5.42%
Return on Capital (ROIC)	2.75%	4.21%	4.53%	9.03%	8.56%	7.19%
Return on Capital Employed (ROCE)	4.30%	6.40%	6.80%	13.10%	11.80%	10.50%
Earnings Yield	2.58%	3.30%	3.17%	2.99%	2.94%	1.84%
FCF Yield	1.31%	1.49%	0.56%	1.68%	1.34%	2.94%
Dividend Yield	1.39%	1.36%	1.31%	0.74%	0.57%	0.61%
Payout Ratio	53.61%	44.48%	35.16%	27.04%	14.30%	14.98%
Buyback Yield / Dilution	0.33%	0.37%	0.20%	-0.06%	2.43%	-30.55%
Total Shareholder Return	1.71%	1.73%	1.51%	0.68%	3.01%	-29.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.